Correction: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active
Luca Giordano, Manish K. Aneja, Natascha Sommer, Nasim Alebrahimdehkordi, Alireza Seraji, Norbert Weissmann, Carsten Rudolph, Christian Plank, Howard T. Jacobs, Marten Szibor
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Research and Treatments · Advanced Nanomaterials in Catalysis · RNA Interference and Gene Delivery
Correction to: Gene Therapy 10.1038/s41434-021-00235-z, published online 04 March 2021
We have become aware of an error in Supplementary Fig. 2 of this paper. Two loading controls for a western blot (ɑ-Tubulin and GAPDH) were immunolabeled on the same membrane and thus showed a similar expression pattern. Due to an unfortunate oversight, we cropped and presented ɑ-Tubulin twice. We here provide a corrected Supplementary Fig. 2b, replacing the erroneous panels with a new one from the original immunoblot, that now shows both ɑ-Tubulin (Cell Signaling, Cat. # 3873) and GAPDH (Cell Signaling, Cat. # 2118S) expression. Of note, the interpretation of the presented data is unchanged.
Supplementary information
Supplemental Material